this article uses the spaced "Alka Lean" for readability
Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1s or GLP-1 RAs, are medications that mimic the effects of the natural hormone GLP-1 your body releases after eating
While short-term research (4-8 weeks) has been extensively studied and often shows good tolerability, long-term safety data is more limited, and several theoretical concerns warrant careful consideration
Understanding whether GLP-1 meds and Hashimoto's can be safely managed together is essential for informed treatment decisions
The bottleneck layer, positioned at the deepest level of the network, utilizes a residual block with 16N filters to capture abstract, high-level features necessary for segmentation
Cardiovascular mortality was significantly reduced with semaglutide and naltrexone plus bupropion, whereas the impact of tirzepatide cannot yet be established, as CVOTs are currently being analyzed